Skip to Content

MYLAN CF 135 MYLAN CF 135 (Fenofibric Acid Delayed-Release 135 mg)

Pill with imprint MYLAN CF 135 MYLAN CF 135 is Blue & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Mylan Pharmaceuticals Inc..

Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN CF 135 MYLAN CF 135

Fenofibric acid delayed-release 135 mg MYLAN CF 135 MYLAN CF 135
Fenofibric acid delayed-release 135 mg MYLAN CF 135 MYLAN CF 135
Fenofibric acid delayed-release 135 mg MYLAN CF 135 MYLAN CF 135

Fenofibric Acid Delayed-Release

Imprint
MYLAN CF 135 MYLAN CF 135
Strength
135 mg
Color
Blue & Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00378-2590 Mylan Pharmaceuticals Inc.
51079-0196 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.